GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 34 filers reported holding GT BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | -33.3% | 10,110 | 0.0% | 0.00% | – |
| Q2 2023 | $3 | -40.0% | 10,110 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | -100.0% | 10,110 | -9.5% | 0.00% | – |
| Q3 2022 | $19,000 | -42.4% | 11,169 | 0.0% | 0.00% | – |
| Q2 2022 | $33,000 | +3.1% | 11,169 | 0.0% | 0.00% | – |
| Q1 2022 | $32,000 | -3.0% | 11,169 | +1.1% | 0.00% | – |
| Q4 2021 | $33,000 | – | 11,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crumly & Associates Inc. | 32,163 | $93,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 20,075 | $58,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,260 | $81,000 | 0.00% |
| Sigma Planning Corp | 21,400 | $62,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 30,000 | $86,000 | 0.00% |
| Gordian Capital Singapore Pte Ltd | 35,000 | $3,000 | 0.00% |
| Welch Group, LLC | 10,000 | $29,000 | 0.00% |
| Renaissance Technologies | 186,300 | $537,000 | 0.00% |
| BRIGHTON JONES LLC | 11,012 | $32,000 | 0.00% |
| Capital Advisors, Ltd. LLC | 24 | $0 | 0.00% |